JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Home・Aktien・Avita Therapeutics Inc

Avita Therapeutics Inc

Geschlossen

4.42 2.79

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.37

Max

4.44

Schlüsselkennzahlen
By Trading Economics
Einkommen	1.6M -12M
Verkäufe	554K 18M
Gewinnspanne	-65.968
Angestellte	226
EBITDA	1.6M -9.7M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+42.57% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	14. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	17M 140M
Vorheriger Eröffnungskurs	1.63
Vorheriger Schlusskurs	4.42

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

8.83 / 9.77 Unterstützung & Widerstand

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Mai 2026, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Requires 365 Retail Markets to Divest Micromarket Kiosk Business to Clear Acquisition of Cantaloupe

1. Mai 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Platforms Acquires Humanoid Robot Startup Assured Robot Intelligence

1. Mai 2026, 18:37 UTC

Wichtige Markttreiber

Senseonic Shares Slide on Underwritten Offering Price

1. Mai 2026, 16:46 UTC

Wichtige Markttreiber

Stellantis, Ferrari Fall on Trump Plan to Increase Tariff on European Cars, Trucks

2. Mai 2026, 19:57 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire CEO Greg Abel Takes the Stage, Making a Case for the Post-Buffett Era -- 3rd Update

2. Mai 2026, 15:24 UTC

Ergebnisse

Berkshire CEO Greg Abel Takes the Stage, Talks Through Quarterly Results -- Update

2. Mai 2026, 12:46 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Profits More Than Double on Gains in Insurance, Railroad, Energy Businesses -- WSJ

2. Mai 2026, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

1. Mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

1. Mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1. Mai 2026, 20:42 UTC

Ergebnisse

Western Digital Beats Earnings Estimates. The Stock Is Falling Anyway. -- Barrons.com

1. Mai 2026, 19:33 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1. Mai 2026, 19:33 UTC

Market Talk

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

1. Mai 2026, 19:18 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Rises for Second Consecutive Week Amid Middle East Standoff -- Market Talk

1. Mai 2026, 19:13 UTC

Market Talk

Natural Gas Rises as Markets Wait for Warmer Temperatures -- Market Talk

1. Mai 2026, 18:36 UTC

Ergebnisse

3 Takeaways From Apple Earnings. The Stock Is Surging. -- Barrons.com

1. Mai 2026, 18:35 UTC

Ergebnisse

Moderna's Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. -- Barrons.com

1. Mai 2026, 18:28 UTC

Ergebnisse

These Stocks Are Today's Movers: Apple, Sandisk, Roblox, Intel, Ferrari, Atlassian, Western Digital, Clorox, Paramount Skydance, and More -- Barrons.com

1. Mai 2026, 18:27 UTC

Market Talk

Gold and Silver Higher for the Day, Lower For The Week -- Market Talk

1. Mai 2026, 18:14 UTC

Akquisitionen, Fusionen, Übernahmen

Barclays Completes Acquisition of Best Egg

1. Mai 2026, 18:04 UTC

Ergebnisse

The First $6 Trillion Company May Not Be Nvidia -- Barrons.com

1. Mai 2026, 17:43 UTC

Market Talk

Home Sales in San Francisco Jump 22.2% in March -- Market Talk

1. Mai 2026, 17:37 UTC

Market Talk

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

1. Mai 2026, 17:30 UTC

Market Talk

Ergebnisse

Apple's 2Q Print, 3Q Guide Set Up Stock to Outperform -- Market Talk

1. Mai 2026, 17:28 UTC

Market Talk

Ergebnisse

Apple's Shift From Net Cash Neutral Goal Seen as Cryptic Signal -- Market Talk

1. Mai 2026, 17:21 UTC

Market Talk

Ergebnisse

Apple Seen Absorbing Higher Memory Costs -- Market Talk

1. Mai 2026, 17:19 UTC

Market Talk

Wichtige Nachrichtenereignisse

U.S. Oil Rig Count Rises by 1 to 408 -- Market Talk

1. Mai 2026, 16:38 UTC

Market Talk

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

1. Mai 2026, 16:23 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Skydance Gets a Double Upgrade. It's the Warner Bros. Deal. -- Barrons.com

1. Mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

42.57% Vorteil

12-Monats-Prognose

Durchschnitt 6.33 USD 42.57%

Hoch 10 USD

Tief 3.5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avita Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.